Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Institutional Investor meetings
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has disclosed its schedule of upcoming analyst and institutional investor meetings under SEBI LODR Regulation 30. Three one-on-one meetings are lined up: a virtual session with ICICI Direct on March 12, 2026, and two in-person meetings in Mumbai with Green Lantern Capital and S Four Capital, both on March 16, 2026. The company has noted that the schedule and mode of meetings may change due to unforeseen circumstances. The disclosure is routine and aimed at ensuring transparency with the stock exchanges.
This is a routine compliance disclosure and does not carry any material impact on the stock price. However, it reflects active investor engagement by the company, which may help improve visibility and analyst coverage.